O
THRD

OrbiMed’s Third Harmonic Bio THRD Stock Holding History

OrbiMed’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,779,071
Closed -$31.4M – 126
2025
Q2 		$31.4M Hold
5,779,071
– – 0.79% 32
2025
Q1 		$20.1M Hold
5,779,071
– – 0.48% 45
2024
Q4 		$59.5M Hold
5,779,071
– – 1.23% 27
2024
Q3 		$78.3M Hold
5,779,071
– – 1.43% 21
2024
Q2 		$75.1M Hold
5,779,071
– – 1.49% 18
2024
Q1 		$54.6M Hold
5,779,071
– – 1% 33
2023
Q4 		$63.4M Hold
5,779,071
– – 1.27% 29
2023
Q3 		$36.9M Hold
5,779,071
– – 0.79% 48
2023
Q2 		$27.8M Hold
5,779,071
– – 0.51% 60
2023
Q1 		$23.8M Hold
5,779,071
– – 0.47% 61
2022
Q4 		$24.9M Hold
5,779,071
– – 0.48% 60
2022
Q3 		$110K Buy
+5,779,071
New +$104M 2.04% 10

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $2.76B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $674M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $2.64B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return